BFC Planning’s Caris Life Sciences CAI Stock Holding History
Bought
Maintained
Sold
Other funds holding CAI
BFC Planning's CAI Position: Q3 2026 in Review
BFC Planning held its Caris Life Sciences (CAI) position steady in Q3 2026 at 32 shares worth $980. The position accounts for ﹤0.01% of the portfolio, ranked #3165.
BFC Planning first reported a position in CAI in Q4 2025 and has held it in 4 quarters since. 252 funds tracked by Wall St. Rank hold CAI as of Q3 2026.
- BFC Planning held 32 shares of Caris Life Sciences worth $980 as of Q3 2026.
- BFC Planning left its Caris Life Sciences share count unchanged in Q3 2026.
- Caris Life Sciences made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3165 holding.
- BFC Planning first reported a position in Caris Life Sciences in Q4 2025 and has held it in 4 quarters since.
- 252 funds tracked by Wall St. Rank held Caris Life Sciences as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.